Development of Safe and Effective Botanical Dietary Supplements

Journal of Medicinal Chemistry

Volumn 58, Issue 21, 2015, Pages 8360-8372

  Van Breemen, Richard B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PRENYLNARINGEN; 8 PRENYLNARINGENIN; DAIDZEIN; DRUG METABOLIZING ENZYME; EQUOL; ISOXANTHOHUMOL; NATURAL PRODUCT; RESVERATROL; UNCLASSIFIED DRUG; XANTHOHUMOL; BIOLOGICAL PRODUCT; PLANT MEDICINAL PRODUCT;

CACO 2 CELL LINE; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HERB DRUG INTERACTION; HUMAN; NONHUMAN; REVIEW; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADVERSE EFFECTS; ANIMAL; CLINICAL TRIAL (TOPIC); DIETARY SUPPLEMENT; DRUG DEVELOPMENT; METABOLISM; PRECLINICAL STUDY; PROCEDURES; TOXICITY;

ANIMALS; BIOLOGICAL PRODUCTS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; HUMANS; PLANT PREPARATIONS;

EID: 84947216744     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b00417     Document Type: Review

References (87)

1. Mahady, G. B. Global Harmonization of Herbal Health Claims J. Nutr. 2001, 131, 1120S-1123S
2. Bannerman, R.; Burton, J.; Chen, W. C. Traditional Medicine and Health Care Coverage; World Health Organization: Geneva, Switzerland, 1983.
3. Bailey, R. L.; Gahche, J. J.; Lentino, C. V.; Dwyer, J. T.; Engel, J. S.; Thomas, P. R.; Betz, J. M.; Sempos, C. T.; Picciano, M. F. Dietary Supplement Use in the United States, 2003-2006 J. Nutr. 2011, 141, 261-266 10.3945/jn.110.133025
4. Herbal Supplements and Remedies. http://www.marketresearch.com/Global-Industry-Analysts-v1039/Herbal-Supplements-Remedies-7544379/ Accessed Mar 13, 2015.
5. Dietary Supplement Health and Education Act of 1994. Public Law 103-417: 103rd Congress. October 25, 1994. http://dshedu.com/DSHEA-Legal/dshea.html. Accessed Mar 13, 2015.
6. Lindstrom, A.; Ooyen, C.; Lynch, M. E.; Blumenthal, M.; Kawa, K. Sales of Herbal Supplements Increase by 7.9% in 2013, Marking a Decade of Rising Sales Herbalgram 2014, 103, 52-56
7. Ajazuddin; Saraf, S. Legal Regulations of Complementary and Alternative Medicines in Different Countries Pharmacogn. Rev. 2012, 6, 154-160 10.4103/0973-7847.99950
8. Miroddi, M.; Mannucci, C.; Mancari, F.; Navarra, M.; Calapai, G. Research and Development for Botanical Products in Medicinals and Food Supplements Market. Evidence-Based Complement. Alter. Med. 2013. DOI: 10.1155/2013/649720. Accessed Mar 13, 2015.
9. Franz, C.; Chizzola, R.; Novak, J.; Sponza, S. Botanical Species Being Used for Manufacturing Plant Food Supplements (PFS) and Related Products in the EU Member States and Selected Third Countries Food Funct. 2011, 2, 720-730 10.1039/c1fo10130g
10. van Breemen, R. B.; Fong, H. H. S.; Farnsworth, N. R. The Role of Quality Assurance and Standardization in the Safety of Botanical Dietary Supplements Chem. Res. Toxicol. 2007, 20, 577-582 10.1021/tx7000493
11. Guidance for Industry: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Small Entity Compliance Guide; U.S. Food and Drug Administration: College Park, MD, December 2010.
12. Dietary Supplements: An Advertising Guide for Industry; Federal Trade Commission: Washington, DC, Nov 18, 1998; p 9.
13. Dolan, L. C.; Matulka, R. A.; Burdock, G. A. Naturally Occurring Food Toxins Toxins 2010, 2, 2289-2332 10.3390/toxins2092289
14. NCCIH Policy: Natural Product Integrity. https://nccih.nih.gov/research/policies/naturalproduct.htm. Accessed Mar 13, 2015.
15. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. http://apps.who.int/medicinedocs/index/assoc/s14878e/s14878e.pdf. Accessed Mar 13, 2015.
16. Xu, H.; Fabricant, D. S.; Piersen, C. E.; Bolton, J. L.; Pezzuto, J. M.; Fong, H.; Totura, S.; Farnsworth, N. R.; Constantinou, A. I. A Preliminary RAPD-PCR Analysis of Cimicifuga Species and Other Botanicals Used for Women's Health Phytomedicine 2002, 9, 757-762 10.1078/094471102321621403
17. Heubl, G. New Aspects of DNA-based Authentication of Chinese Medicinal Plants by Molecular Biological Techniques Planta Med. 2010, 76, 1963-1974 10.1055/s-0030-1250519
18. Zhang, X.-J.; Huang, L.-L.; Cai, X.-J.; Li, P.; Wang, Y.-T.; Wan, J.-B. Fatty Acid Variability in Three Medicinal Herbs of Panax Species. Chem. Cent. J. 2013, 7, 12. DOI: 10.1186/1752-153X-7-12. Published online January 21, 2013.
19. Reich, E.; Schibli, A.; DeBatt, A. Validation of High-Performance Thin-Layer Chromatographic Methods for the Identification of Botanicals in a cGMP Environment J. AOAC Int. 2008, 91, 13-20
20. Zhao, J.; Avula, B.; Joshi, V. C.; Techen, N.; Wang, Y. H.; Smillie, T. J.; Khan, I. A. NMR Fingerprinting for Analysis of Hoodia Species and Hoodia Dietary Products Planta Med. 2011, 77, 851-857 10.1055/s-0030-1250583
21. Pongkitwitoon, B.; Sakamoto, S.; Morinaga, O.; Juengwatanatrakul, T.; Shoyama, Y.; Tanaka, H.; Morimoto, S. Single-Chain Variable Fragment Antibody Against Ginsenoside Re as an Effective Tool for the Determination of Ginsenosides in Various Ginsengs J. Nat. Med. 2011, 65, 24-30 10.1007/s11418-010-0446-1
22. Greene, L. A.; Isaac, I.; Gray, D. E.; Schwartz, S. A. Streamlining Plant Sample Preparation: The Use of High-Throughput Robotics to Process Echinacea Samples for Biomarker Profiling by MALDI-TOF Mass Spectrometry J. Biomol. Technol. 2007, 18, 238-244
23. Eugster, P. J.; Guillarme, D.; Rudaz, S.; Veuthey, J. L.; Carrupt, P. A.; Wolfender, J. L. Ultra High Pressure Liquid Chromatography for Crude Plant Extract Profling J. AOAC Int. 2011, 94, 51-70
24. Mulabagal, V.; Calderón, A. I. Liquid Chromatography/Mass Spectrometry Based Fingerprinting Analysis and Mass Profiling of Euterpe oleracea (Açaí) Dietary Supplement Raw Materials Food Chem. 2012, 134, 1156-1164 10.1016/j.foodchem.2012.02.123
25. van der Kooy, F.; Maltese, F.; Hae Choi, Y.; Kyong Kim, H.; Verpoorte, R. Quality Control of Herbal Material and Phytopharmaceuticals with MS and NMR Cased Metabolic Fingerprinting Planta Med. 2009, 75, 763-75 10.1055/s-0029-1185450
26. Khan, I. A. Issues Related to Botanicals Life Sci. 2006, 78, 2033-2038 10.1016/j.lfs.2005.12.019
27. Vanherweghem, J.-L.; Depierreux, M.; Tielemans, C.; Abramowicz, D.; Dratwa, M.; Jadoul, M.; Richard, C.; Vandervelde, D.; Verbeelen, D.; Vanhaelen-Fastre, R.; Vanhaelen, M. Rapidly Progressive Interstitial Renal Fibrosis in Young Women: Association with Slimming Regimen Including Chinese Herbs Lancet 1993, 341, 387-391 10.1016/0140-6736(93)92984-2
28. Vanhaelen, M.; Vanhaelen-Fastre, R.; But, P.; Vanherweghem, J.-L. Identification of Aristolochic Acid in Chinese Herbs Lancet 1994, 343, 174 10.1016/S0140-6736(94)90964-4
29. Working Party on Herbal Medicinal Products. Position Paper on the Risks Associated with the Use of Herbal Products Containing Aristolochia Species. EMEA, The European Agency for the Evaluation of Medicinal Products: London, 2000; pp 1-10; http://www.ema.europa.eu/docs/en-GB/document-library/Position-statement/2009/11/WC500015537.pdf. Accessed Mar 13, 2015.
30. Slifman, N. R.; Obermeyer, W. R.; Aloi, B. K.; Musser, S. M.; Correll, W. A., Jr.; Cichowicz, S. M.; Betz, J. M.; Love, L. A. Contamination of Botanical Dietary Supplements by Digitalis lanata N. Engl. J. Med. 1998, 339, 806-811 10.1056/NEJM199809173391204
31. Inspections, Compliance, Enforcement, and Criminal Investigations. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2014/default.htm? Accessed May 26, 2015.
32. New York Attorney General Targets Supplements at Major Retailers. http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-targets-supplements-at-major-retailers/?-r=0. Accessed Mar 13, 2015.
33. NY Attorney General Expands Herbal Supplements Investigation. http://www.nytimes.com/aponline/2015/02/24/us/ap-us-herbal-supplements-investigation.html, Accessed Mar 13, 2015.
34. Abdullah, T.; Radu, S.; Hassan, Z.; Hashim, J. K. Detection of Genetically Modified Soy in Processed Foods Sold Commercially in Malaysia by PCR-Based Method Food Chem. 2006, 98, 575-579 10.1016/j.foodchem.2005.07.035
35. Weller, M. G. A Unifying Review of Bioassay-Guided Fractionation, Effect-Directed Analysis and Related Techniques Sensors 2012, 12, 9181-9209 10.3390/s120709181
36. Shin, Y. G.; van Breemen, R. B. Analysis and Screening of Combinatorial Libraries Using Mass Spectrometry Biopharm. Drug Dispos. 2001, 22, 353-372 (Review) 10.1002/bdd.278
37. Choi, Y.; van Breemen, R. B. Development of a Screening Assay for Ligands to the Estrogen Receptor Based on Magnetic Microparticles and LC-MS Comb. Chem. High Throughput Screening 2008, 11, 1-6
38. Farnsworth, N. R.; Krause, E. C.; Bolton, J. L.; Pauli, G. F.; van Breemen, R. B.; Graham, J. G. The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from Plant to Clinical Use Am. J. Clin. Nutr. 2008, 87, 504s-508s
39. Krause, E.; Yuan, Y.; Hajirahimkhan, A.; Dong, H.; Dietz, B. M.; Nikolic, D.; Pauli, G. F.; Bolton, J. L.; van Breemen, R. B. Biological and Chemical Standardization of a Hop (Humulus lupulus) Botanical Dietary Supplement Biomed. Chromatogr. 2014, 28, 729-734 10.1002/bmc.3177
40. Piersen, C. E.; Booth, N. L.; Sun, Y.; Liang, W.; Burdette, J. E.; van Breemen, R. B.; Geller, S. E.; Gu, C.; Banuvar, S.; Shulman, L. P.; Bolton, J. L.; Farnsworth, N. R. Chemical and Biological Characterization and Clinical Evaluation of Botanical Dietary Supplements: a Phase I Red Clover Extract as a Model Curr. Med. Chem. 2004, 11, 1361-1374 10.2174/0929867043365134
41. Geller, S. E.; Shulman, L. P.; van Breemen, R. B.; Banuvar, S.; Zhou, Y.; Epstein, G.; Hedayat, S.; Nikolic, D.; Krause, E. C.; Piersen, C. E.; Bolton, J. L.; Pauli, G. F.; Farnsworth, N. R. Safety and Efficacy of Black Cohosh and Red Clover for the Management of Vasomotor Symptoms: a Randomized Controlled Trial Menopause 2009, 16, 1156-1166 10.1097/gme.0b013e3181ace49b
42. USP Dietary Supplement Standards. http://www.usp.org/dietary-supplements/overview. Accessed May 27, 2015.
43. Stakeholder Panel on Dietary Supplements (SPDS). http://www.aoac.org/iMIS15-Prod/AOAC/SD/SPDS/AOAC-Member/SH/SPDSCF/SPDSM.aspx?hkey=b8cbd524-33d1-4e51-8cc0-4e2028c367f2. Accessed May 27, 2015.
44. Calani, L.; Brighenti, F.; Bruni, R.; Del Rio, D. Absorption and Metabolism of Milk Thistle Flavanolignans in Humans Phytomedicine 2012, 20, 40-46 10.1016/j.phymed.2012.09.004
45. Zhu, H. J.; Brinda, B. J.; Chavin, K. D.; Bernstein, H. J.; Patrick, K. S.; Markowitz, J. S. An Assessment of Pharmacokinetics and Antioxidant Activity of Free Silymarin Flavonolignans in Healthy Volunteers: a Dose Escalation Study Drug Metab. Dispos. 2013, 41, 1679-1685 10.1124/dmd.113.052423
46. Legette, L.; Karnpracha, C.; Reed, R. L.; Choi, J.; Bobe, G.; Christensen, J. M.; Rodriguez-Proteau, R.; Purnell, J. Q.; Stevens, J. F. Human Pharmacokinetics of Xanthohumol, an Antihyperglycemic Flavonoid from Hops Mol. Nutr. Food Res. 2014, 58, 248-255 10.1002/mnfr.201300333
47. van Breemen, R. B.; Yuan, Y.; Banuvar, S.; Shulman, L. P.; Qiu, X.; Ramos Alvarenga, R. F.; Chen, S.-N.; Dietz, B. M.; Bolton, J. L.; Pauli, G. F.; Krause, E.; Viana, M.; Nikolic, D. Pharmacokinetics of Prenylated Hop Phenols in Women Following Oral Administration of a Standardized Extract of Hops Mol. Nutr. Food Res. 2014, 58, 1962-1969 10.1002/mnfr.201400245
48. Nikolic, D.; Li, Y.; Chadwick, L. R.; van Breemen, R. B. In Vitro Studies of Intestinal Permeability and Hepatic and Intestinal Metabolism of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops (Humulus lupulus L.) Pharm. Res. 2006, 23, 864-872 10.1007/s11095-006-9902-8
49. Hidalgo, I. J.; Raub, T. J.; Borchardt, R. T. Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability Gastroenterology 1989, 96, 736-749
50. Artursson, P.; Karlsson, J. Correlation between Oral Drug Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells Biochem. Biophys. Res. Commun. 1991, 175, 880-885 10.1016/0006-291X(91)91647-U
51. van Breemen, R. B.; Liang, W.; Banuvar, S.; Shulman, L. P.; Pang, Y.; Tao, Y.; Nikolic, D.; Krock, K. M.; Fabricant, D. S.; Chen, S. N.; Hedayat, S.; Bolton, J. L.; Pauli, G. F.; Piersen, C. E.; Krause, E. C.; Geller, S. E.; Farnsworth, N. R. Pharmacokinetics of 23-epi-26-Deoxyactein in Women after Oral Administration of a Standardized Extract of Black Cohosh Clin. Pharmacol. Ther. 2010, 87, 219-225 10.1038/clpt.2009.251
52. Johnson, B. M.; van Breemen, R. B. In Vitro Formation of Quinoid Metabolites of the Dietary Supplement Cimicifuga racemosa (Black Cohosh) Chem. Res. Toxicol. 2003, 16, 838-846 10.1021/tx020108n
53. Lyons, M. M.; Yu, C.; Toma, R. B.; Cho, S. Y.; Reiboldt, W.; Lee, J.; van Breemen, R. B. Resveratrol in Raw and Baked Blueberries and Bilberries J. Agric. Food Chem. 2003, 51, 5867-5870 10.1021/jf034150f
54. Li, Y.; Shin, Y. G.; Yu, C.; Kosmeder, J. W.; Hirschelman, W. H.; Pezzuto, J. M.; van Breemen, R. B. Increasing the Throughput and Productivity of Caco-2 Cell Permeability Assays Using Liquid Chromatography-Mass Spectrometry: Application to Resveratrol Absorption and Metabolism Comb. Chem. High Throughput Screening 2003, 6, 757-767 10.2174/138620703771826865
55. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; van Breemen, R. B. Human, Rat, and Mouse Metabolism of Resveratrol Pharm. Res. 2002, 19, 1907-1914 10.1023/A:1021414129280
56. Wenzel, E.; Somoza, V. Metabolism and Bioavailability of trans-Resveratrol Mol. Nutr. Food Res. 2005, 49, 472-481 10.1002/mnfr.200500010
57. Guo, J.; Liu, D.; Nikolic, D.; Zhu, D.; Pezzuto, J. M.; van Breemen, R. B. In vitro Metabolism of Isoliquiritigenin by Human Liver Microsomes Drug Metab. Dispos. 2008, 36, 461-468 10.1124/dmd.107.018721
58. Guo, J.; Liu, A.; Cao, H.; Luo, Y.; Pezzuto, J. M.; van Breemen, R. B. Biotransformation of the Chemopreventive Agent 2′,4′,4-Trihydroxychalchone (Isoliquiritigenin) by UDP-glucuronosyltransferases Drug Metab. Dispos. 2008, 36, 2104-2112 10.1124/dmd.108.021857
59. Cuendet, M.; Guo, J.; Luo, Y.; Chen, S.; Oteham, C. P.; Moon, R. C.; van Breemen, R. B.; Marler, L. E.; Pezzuto, J. M. Cancer Chemopreventive Activity and Metabolism of Isoliquiritigenin, a Compound Found in Licorice Cancer Prev. Res. 2010, 3, 221-232 10.1158/1940-6207.CAPR-09-0049
60. Soars, M. G.; Gelboin, H. V.; Krausz, K. W.; Riley, R. J. A Comparison of Relative Abundance, Activity Factor and Inhibitory Monoclonal Antibody Approaches in the Characterization of Human CYP Enzymology Br. J. Clin. Pharmacol. 2003, 55, 175-181 10.1046/j.1365-2125.2003.01721.x
61. Guo, J.; Nikolic, D.; Chadwick, L. R.; Pauli, G. F.; van Breemen, R. B. Identification of Human Hepatic Cytochrome P450 Enzymes Involved in the Metabolism of 8-Prenylnaringenin and Isoxanthohumol from Hops (Humulus lupulus L.) Drug Metab. Dispos. 2006, 34, 1152-1159 10.1124/dmd.105.008250
62. Possemiers, S.; Heyerick, A.; Robbens, V.; De Keukeleire, D.; Verstraete, W. Activation of Proestrogens from Hops (Humulus lupulus L.) by Intestinal Microbiota; Conversion of Isoxanthohumol into 8-Prenylnaringenin J. Agric. Food Chem. 2005, 53, 6281-6288 10.1021/jf0509714
63. Fafii, F. The Role of Colonic Bacteria in the Metabolism of the Natural Isoflavone Daidzin to Equol Metabolites 2015, 5, 56-73 10.3390/metabo5010056
64. Hill, L. L.; Foote, J. C.; Erickson, B. D.; Cerniglia, C. E.; Denny, G. S. Echinacea purpurea supplementation stimultates select groups of human gastrointestinal tract microbiota J. Clin. Pharm. Ther. 2006, 31, 599-604 10.1111/j.1365-2710.2006.00781.x
65. Nikolic, D.; Fan, P. W.; Bolton, J. L.; van Breemen, R. B. Screening for Xenobiotic Electrophilic Metabolites Using Pulsed Ultrafiltration-Mass Spectrometry Comb. Chem. High Throughput Screening 1999, 2, 165-176
66. van Breemen, R. B.; Bolton, J. L. U.S. Patent No. US 6,995,022 B1. Screening of Xenobiotics and Endogenous Compounds for Metabolic Transformation, Formation of Toxic Metabolites, and Bioavailability. February 7, 2006, (filed December 23, 1999).
67. Johnson, B. M.; Bolton, J. L.; van Breemen, R. B. Screening Botanical Extracts for Quinoid Metabolites Chem. Res. Toxicol. 2001, 14, 1546-1551 10.1021/tx010106n
68. Johnson, B. M.; Qiu, S.-X.; Zhang, S.; Zhang, F.; Burdette, J. E.; Yu, L.; Bolton, J. L.; van Breemen, R. B. Identification of Novel Electrophilic Mammalian Metabolites of Piper methysticum Forst. (Kava) Chem. Res. Toxicol. 2003, 16, 733-740 10.1021/tx020113r
69. Huang, K.; Huang, L.; van Breemen, R. B. Detection of Reactive Metabolites Using Isotope-Labeled Glutathione Trapping and Simultaneous Neutral Loss and Precursor Ion Scanning with Ultra-High-Pressure Liquid Chromatography Triple Quadruple Mass Spectrometry Anal. Chem. 2015, 87, 3646-3654 10.1021/ac504737x
70. Guidance for Industry. Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations; FDA: Silver Spring, MD, February, 2012.
71. Yuan, Y.; Qiu, X.; Nikolić, D.; Chen, S.-N.; Huang, K.; Li, G.; Pauli, G. F.; van Breemen, R. B. Inhibition of Human Cytochrome P450 Enzymes by Hops (Humulus lupulus) and Hop Prenylphenols Eur. J. Pharm. Sci. 2014, 53, 55-61 10.1016/j.ejps.2013.12.003
72. Yu, C.; Shin, Y. G.; Kosmeder, J. W.; Pezzuto, J. M.; van Breemen, R. B. Liquid Chromatography/Tandem Mass Spectrometric Determination of Human Cytochrome P450 Isozymes by Resveratrol and Resveratrol-3-sulfate Rapid Commun. Mass Spectrom. 2003, 17, 307-313 10.1002/rcm.918
73. Li, J.; Gödecke, T.; Chen, S. N.; Imai, A.; Lankin, D. C.; Farnsworth, N. R.; Pauli, G. F.; van Breemen, R. B.; Nikolić, D. In Vitro Metabolic Interactions between Black Cohosh (Cimicifuga racemosa) and Tamoxifen via Inhibition of Cytochromes P450 2D6 and 3A4 Xenobiotica 2011, 41, 1021-1030 10.3109/00498254.2011.603385
74. Foster, B. C.; Vandenhoek, S.; Tang, R.; Budzinski, J. W.; Krantis, A.; Li, K. Y. Effects of Several Chinese Natural Health Products on Human Cytochrome P450 Metabolism J. Pharm. Pharm. Sci. 2002, 5, 185-189
75. Gurley, B. J.; Gardner, S. F.; Hubbard, M. A.; Williams, D. K.; Gentry, W. B.; Cui, Y.; Ang, C. Y. W. Cytochrome P450 Phenotypic Ratios for Predicting Herb-Drug Interactions in Humans Clin. Pharmacol. Ther. 2002, 72, 276-287 10.1067/mcp.2002.126913
76. Venkataramanan, R.; Ramachandran, V.; Komoroski, B. J.; Zhang, S.; Schiff, P. L.; Strom, S. C. Milk Thistle, a Herbal Supplement, Decreases the Activity of CYP3A4 and Uridine Diphosphoglucuronosyl Transferase in Human Hepatocyte Cultures Drug Metab. Dispos. 2000, 28, 1270-1273
77. Gurley, B. J.; Gardner, S. F.; Hubbard, M. A.; Williams, D. K.; Gentry, W. B.; Carrier, J.; Khan, I. A.; Edwards, D. J.; Shah, A. In Vivo Assessment of Botanical Supplementation on Human Cytochrome P450 Phenotypes: Citrus aurantium, Echinacea purpurea, Milk Thistle, and Saw Palmetto Clin. Pharmacol. Ther. 2004, 76, 428-440 10.1016/j.clpt.2004.07.007
78. Schehrer, L.; Regan, J. D.; Westendorf, J. UDS Induction by an Array of Standard Carcinogens in Human and Rodent Hepatocytes: Effect of Cryopreservation Toxicology 2000, 147, 177-191 10.1016/S0300-483X(00)00190-6
79. Reinach, B.; de Sousa, G.; Dostert, P.; Ings, R.; Gugenheim, J.; Rahmani, R. Comparative Effects of Rifabutin and Rifampicin on Cytochromes P450 and UDP-Glucuronosyl-Transferases Expression in Fresh and Cryopreserved Human Hepatocytes Chem.-Biol. Interact. 1999, 121, 37-48 10.1016/S0009-2797(99)00089-7
80. Nishimura, M.; Imai, T.; Morioka, Y.; Kuribayashi, S.; Kamataki, T.; Naito, S. Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes Drug Metab. Pharmacokinet. 2004, 19, 422-429 10.2133/dmpk.19.422
81. Jin, H.; Di, L. Permeability - In Vitro Assays for Assessing Drug Transporter Activity Curr. Drug Metab. 2008, 9, 911-920 10.2174/138920008786485056
82. Tirona, R. B.; Bailey, D. G. Herbal Product-Drug Interactions Mediated by Induction Br. J. Clin. Pharmacol. 2006, 61, 677-681 10.1111/j.1365-2125.2006.02684.x
83. Wentworth, J. M.; Agostini, M.; Love, J.; Schwabe, J. W.; Chatterjee, V. K. K. St. John's Wort, a Herbal Antidepressant, Activates the Steroid X Receptor J. Endocrinol. 2000, 166, R11-R16 10.1677/joe.0.166R011
84. Diana Di Mavungu, J.; Monbaliu, S.; Scippo, M. L.; Maghuin-Rogister, G.; Schneider, Y. J.; Larondelle, Y.; Callebaut, A.; Robbens, J.; Van Peteghem, C.; De Saeger, S. LC-MS/MS Multi-analyte Method for Mycotoxin Determination in Food Supplements Food Addit. Contam., Part A 2009, 26, 885-895 10.1080/02652030902774649
85. Soller, R. W.; Bayne, H. J.; Shaheen, C. The Regulated Dietary Supplement Industry: Myths of an Unregulated Industry Dispelled HerbalGram 2012, 93, 42-57
86. Shulman, L. P.; Banuvar, S.; Fong, H. H.; Farnsworth, N. R. Discussion of a Well-Designed Clinical Trial which did not Demonstrate Effectiveness: UIC Center for Botanical Dietary Supplements Research Study of Black Cohosh and Red Clover Fitoterapia 2011, 82, 88-91 10.1016/j.fitote.2010.10.013
87. Food and Drug Administration. Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk Fed. Register 2004, 69, 6787-6854